ICMR shortlisted 21 hospitals for plasma trials

NEW DELHI: The Indian Council of Medical Research (ICMR) has shortlisted 21 hospitals to conduct clinical trials for plasma therapy, which uses antibodies from the blood of cured patients, to treat Covid-19 patients.

Soon, Clinical trials will be conducted by five hospitals in Maharashtra, four in Gujarat, two each in Rajasthan, Tamil Nadu, Madhya Pradesh and Uttar Pradesh, and
one each in Punjab, Karnataka, Telangana and Chandigarh

All You Need to Know About Plasma therapy:

The plasma therapy includes drawing out whole blood from a recovered patient from Covid-19 by separating the plasma. Nearly 400 ml plasma is drawn out from one person, which can be used to treat another two patients.

90 hospitals are in queue
Other 90 hospitals, including seven in Delhi, are under consideration for participating in the clinical trials. Hospitals in the capital which are awaiting approval include AIIMS, Indraprastha Apollo, Batra Hospital and Medical Research Centre, Lady Hardinge Medical College, RML Hospital, Max Hospital-Saket and Indian Red Cross Society.

The health ministry had termed as “illegal” any use of the therapy beyond clinical trials earlier on 29th April. “The therapy can create life threatening conditions,” the ministry had said.

  • Related Posts

    • Health
    • July 23, 2025
    • 114 views
    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    ‘Made in India’ Surgical Robot does a Trailblazer between India & France France/ India: Two continents as it were shrunk to an operation theatre, thanks to Made in India surgical…

    • Health
    • July 18, 2025
    • 744 views
    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Prodigal ‘Surgeon’ Son returns from London to put Bihar on Robotic Surgery Map New Delhi: Bihar healthcare may be on the cusp of being cutting edge as prospect of its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra